Made available in DSpace on 2014-12-17T15:32:16Z (GMT). No. of bitstreams: 1
RuthLFX.pdf: 2397744 bytes, checksum: 8d25a9f2aa705aa972d7a1d4de2b1b29 (MD5)
Previous issue date: 2008-02-28 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / The purpose of this study was to assess the immunohistochemical expression of CD105 and FvW antibodies in the angiogenesis of oral epidermoid carcinoma
(OEC), correlating it with the TNM clinical staging system, seeking a better understanding of its biological behavior and use as an indicator of prognosis.The sample consisted of 30 epidermoid carcinoma (EC) cases, 10 of the floor of the
mouth, 10 of the retromolar region and 10 of the tongue, in addition to 10 cases of pyogenic granuloma, which made up the control group. The results showed that mean microvessel counts (MVC) were correspondingly higher in the pyogenic
granuloma group (CD105 = 57.26 vessels and FvW = 39.64) than in the EC group (CD105 = 10.09 and FvW = 12.20) and that the differences were statistically significant between the groups for each of the angiogenic biomarkers (p = 0.002 for
CD105 and p< 0.001 for FvW). CD105 had better positivity in the pyogenic granuloma group (mean = 57.26 vessels) and for EC, FvW had the highest expression (mean = 12.20 vessels). With respect to EC, the most affected age group
was between 51 and 70 years (n = 14; 46.7%), with a representative MVC for both markers. No statistically significant difference was found between the sexes for any
of the markers (p = 0.967 for CD105 and p = 0.744 for FvW). Mean CD105 levels were much higher in patients with stage T3 and T4 (17.13) and lower in those with stage N+ (6.36). Mean FvW levels were higher in the patients with stage T1 and T2 (12.23) and lower in patients with T3 and T4 (12.10), but without a statistically significant difference. In regard to anatomic location, a statistically significant difference was observed between FvW sites, with a statistically significant difference between floor of the mouth cases and those located in the retromolar region (p =0.013). Therefore, this study suggests that CD105 expression in OEC angiogenesis,
in contrast to other types of malignant neoplasias, may not be correlated with prognosis and tumor aggressiveness, whereas FvW was a more effective antibody for staining this lesion / Nesta pesquisa buscou-se avaliar a express?o imunoistoqu?mica dos anticorpos CD105 e FvW na angiog?nese do Carcinoma Epiderm?ide Oral (CEO), correlacionando-o com o estadiamento cl?nico pelo sistema TNM, visando uma
melhor compreens?o do seu comportamento biol?gico e utiliza??o como indicador de progn?stico. A amostra foi composta por 30 casos de CE, sendo 10 de assoalho
bucal, 10 da regi?o retromolar e 10 de l?ngua, al?m de 10 casos de granuloma piog?nico, integrantes do grupo controle. Os resultados desta pesquisa mostraram que as m?dias da MVC foram correspondentemente mais elevadas no grupo do
granuloma piog?nico (CD105 = 57,26 vasos e FvW = 39,64) do que no grupo do CE (CD105 = 10,09 e FvW = 12,20) e as diferen?as se revelaram estatisticamente significantes entre os grupos para cada um dos biomarcadores angiog?nicos
(p=0,002 para o CD105 e p<0,001 para o FvW ). O CD105 se mostrou com melhor positividade no granuloma piog?nico (m?dia = 57,26 vasos) e, para o CE, o FvW foi o que apresentou maior marca??o (m?dia = 12,20 vasos). Com rela??o ao CE, a faixa et?ria mais acometida foi entre 51 e 70 anos (n=14; 46,7%), apresentando uma MVC representativa para ambos os marcadores. N?o se comprovou diferen?a
estatisticamente significante entre os sexos para nenhum dos marcadores (p=0,967 para o CD105 e p=0,744 para o FvW). A m?dia do CD105 foi bem mais elevada entre os pacientes com estadiamento T3 e T4 (17,13) e menos elevada entre os
pacientes com estadiamento N+ (6,36). Quando se avaliou o FvW, a m?dia foi mais elevada no grupo dos pacientes com T1 e T2 (12,23), sendo mais baixa nos pacientes com T3 e T4 (12,10), por?m sem diferen?a estatisticamente significante.
Em rela??o ? localiza??o anat?mica, comprovou-se diferen?a estatisticamente significante entre as localiza??es assoalho bucal e retromolar (p=0,013) para o marcador FvW. Portanto, este estudo sugere que a marca??o do CD105 na
angiog?nese do CEO, ao contr?rio de outros tipos de neoplasias malignas, pode n?o estar correlacionada com o progn?stico e agressividade do tumor, enquanto que o
FvW se mostrou um anticorpo mais efetivo na marca??o desta les?o
| Identifer | oai:union.ndltd.org:IBICT/oai:repositorio.ufrn.br:123456789/17100 |
| Date | 28 February 2008 |
| Creators | Xavier, Ruth Lopes de Freitas |
| Contributors | http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787928A2, Cruz, Maria Carmen Fontoura Nogueira da, CPF:33243158320, http://lattes.cnpq.br/8702018716079552, Souza, L?lia Batista de, http://buscatextual.cnpq.br/buscatextual/visualizacv.do?id=K4787927Z7&dataRevisao=null, Pinto, Le?o Pereira |
| Publisher | Universidade Federal do Rio Grande do Norte, Programa de P?s-Gradua??o em Patologia Oral, UFRN, BR, Odontologia |
| Source Sets | IBICT Brazilian ETDs |
| Language | Portuguese |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, info:eu-repo/semantics/masterThesis |
| Format | application/pdf |
| Source | reponame:Repositório Institucional da UFRN, instname:Universidade Federal do Rio Grande do Norte, instacron:UFRN |
| Rights | info:eu-repo/semantics/openAccess |
Page generated in 0.0106 seconds